Close

Dr Sedona Sweeney

Assistant Professor
in Health Economics

Room
327

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

Tel.
020 7927 2890

Sedona is a health economist, with a research focus on economic evaluation in low- and middle-income settings.  Her particular interest is in the economic impact of substantial long-term health shocks, both at the provider level and within the household. Her research to date has been focused on measurement and understanding of the costs of chronic illness – including HIV, TB, chronic non-communicable diseases, and HCV

ORCiD

ResearchGate profile

Affiliations

Department of Global Health and Development
Faculty of Public Health and Policy

Centres

Centre for Evaluation
TB Centre

Teaching

Sedona is the Deputy Module Organizer for the Distance Learning module on the Economics of Global Health Policy.  She also supervises in-person MSc students on the Health Policy, Planning, and Financing course.

Research

Sedona's current research projects include:

  • TB PRACTECAL: a phase II/III clinical research project to find short, tolerable and effective treatments for people with drug-resistant tuberculosis (DR-TB)
  • XACT-III: a pragmatic, multi-country, open-labelled, randomised controlled trial to evaluate a scalable active case finding intervention for TB using a point-of-care molecular tool
  • FEND-TB: a global research consortium supporting the evaluation of early-stage TB diagnostics & novel diagnostic strategies in the context of existing clinical algorithms in TB endemic countries
  • iHOST: an intervention that aims to improve hospital care for people who use opioids by removing barriers to opioid withdrawal management.
  • TB MAC: the TB Modelling and Analysis Consortium
Past involvement in research projects includes:
  • VALUE-TB: a collaboration between LSHTM, University of Cape Town, and WHO aiming to collect cost data to facilitate decision-making for TB in five countries (incl. Kenya, Ethiopia, Philippines, India, and Georgia)
  • the Global Health Cost Consortium: which aims to mitigate the TB and HIV epidemics by systematically improving the availability, quality, timing, relevance, interpretation, and use of cost information on HIV and tuberculosis (TB) programs and services
  • the Integra Initiative: an analysis of integrated HIV and sexual and reproductive health services in Kenya and Swaziland
  • the Health Systems Chronic Disease project: a project aiming to improve the health systems response to chronic disease in Uganda and Tanzania
  • a project assessing the impact and cost-effectiveness of needle/syringe provision on hepatitis C transmission among people who inject drugs in the UK
  • the MERGE project: evaluating a model of scaling-up integrated TB and HIV services in South Africa
Research Area
Economic evaluation
Health systems
Sexual health
Social and structural determinants of health
Equity
Randomised controlled trials
Violence
Discipline
Health economics
Economics
Disease and Health Conditions
Cardiovascular disease
Chronic disease
HIV/AIDS
Sexually transmitted disease
Tuberculosis
Syphilis
Diabetes
Hepatitis
Non-communicable diseases
Country
China
Ethiopia
United Kingdom
India
Kenya
Philippines
Swaziland
Tanzania
Uganda
South Africa
Region
East Asia & Pacific (developing only)
Europe & Central Asia (all income levels)
Least developed countries: UN classification
Sub-Saharan Africa (developing only)

Selected Publications

Cost of TB prevention and treatment in the Philippines in 2017.
Capeding TPJ; Rosa JD; Lam H; Gaviola DG; Garfin AMC; Hontiveros C; Cunnama L; Laurence YV; Kitson N; Vassall A
2022
International Journal of Tuberculosis and Lung Disease
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis
Sweeney S; Berry C; Kazounis E; Motta I; Vassall A; Dodd M; Fielding K; Nyang'wa B-T
2022
medRxiv
Cost of TB services: approach and summary findings of a multi-country study (Value TB).
Sweeney S; Laurence YV; Cunnama L; Gomez GB; Garcia-Baena I; Bhide P; Capeding TJ; Chatterjee S; Chikovani I; Eyob H
2022
International journal of tuberculosis and lung disease
Optimising health benefit packages in the era of COVID-19: A case study from Pakistan (Accepted)
Torres Rueda S; Kitson N; Bozzani F; Sweeney S; Raza W; Murad Shah M; Naylor N; Pearson C; Eggo R; Quaife M
2022
Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries.
Vassall A; Sweeney S; Barasa E; Prinja S; Keogh-Brown MR; Tarp Jensen H; Smith R; Baltussen R; M Eggo R; Jit M
2022
Wellcome open research
Cost of TB services in healthcare facilities in Kenya (No 3).
Kairu A; Orangi S; Oyando R; Kabia E; Nguhiu P; Ong Ang O J; Mwirigi N; Laurence YV; Kitson N; Garcia Baena I
2021
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae.
Menzies NA; Quaife M; Allwood BW; Byrne AL; Coussens AK; Harries AD; Marx FM; Meghji J; Pedrazzoli D; Salomon JA
2021
LANCET GLOBAL HEALTH
See more Publications